Edgestream Partners L.P. lifted its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 19.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 15,433 shares of the financial services provider’s stock after buying an additional 2,535 shares during the quarter. Edgestream Partners L.P.’s holdings in CME Group were worth $4,558,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new stake in CME Group in the fourth quarter valued at approximately $1,523,241,000. Victory Capital Management Inc. raised its stake in shares of CME Group by 746.4% during the fourth quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after purchasing an additional 1,807,491 shares during the period. Life Cycle Investment Partners Ltd purchased a new stake in shares of CME Group during the fourth quarter valued at approximately $217,656,000. Viking Global Investors LP acquired a new position in shares of CME Group during the second quarter worth $164,648,000. Finally, Vanguard Group Inc. lifted its position in shares of CME Group by 1.7% during the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after purchasing an additional 588,509 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
CME Group Stock Performance
Shares of CME opened at $267.79 on Friday. The business’s 50 day moving average is $250.89 and its two-hundred day moving average is $281.05. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The firm has a market cap of $96.29 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 3.11 and a beta of 0.25. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, June 9th. CME Group’s dividend payout ratio is 44.11%.
Analysts Set New Price Targets
Several research analysts have recently weighed in on CME shares. Weiss Ratings downgraded shares of CME Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 13th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. The Goldman Sachs Group cut their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research report on Thursday, June 18th. Finally, JPMorgan Chase & Co. raised their target price on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Eleven research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $291.81.
Check Out Our Latest Stock Report on CME
Insider Buying and Selling at CME Group
In other news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by insiders.
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
